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Muscular dystrophies are progressive myopathic dis-
orders resulting from defects in a number of genes
required for normal muscle function [1]. Duchenne
muscular dystrophy is caused by a defective gene
located on the X chromosome, that is responsible for
the production of dystrophin [2] and is related to other
inherited myopathies like Emery–Dreifuss muscular
dystrophy, Becker muscular dystrophy, limb-girdle
muscular dystrophies, fascioscapulohumeral muscular
dystrophy and myotonic dystrophy. Duchenne mus-
cular dystrophy has a recessive inheritance. The
disease is clinically associated with muscle fiber
degeneration. The incidence is one in 3,500 live male
births, with a prevalence of 3 per 100,000 [3]. The
clinical onset of weakness usually occurs between 2
and 3 years of age [4]. One of the major complications
of Duchenne muscular dystrophy is a dilated cardio-
myopathy. The main cardiac expression of the disease
is extensive fibrosis of the posterobasal and lateral left
ventricular wall. In patients with Duchenne muscular
dystrophy, the incidence of the cardiomyopathy
increases from zero under the age of 10, to one-third
at the age of 14 years to one half at the age of 18 years
and nearly 98% in patients over 18 years [5]. The
incidence of cardiac failure in female carriers is
reported to be 10% even in the absence of skeletal
muscle involvement [6]. However, in these females
carriers, life expectancy is not affected by the
presence of the abnormal gen [7]. The cardiomyopa-
thy can be detected by an abnormal ECG
characterized by tall right precordial R waves with
an increased R/S ratio and deep Q waves in the lateral
leads and by echocardiography showing localised
lateral thinning and akinesia and noncompaction of
the endocardium ultimately progressing in a dilated
cardiomyopathy [8–10]. For early and appropriate
detection of cardiac involvement of muscular dystro-
phy, a recent workshop on the management of cardiac
involvement in muscular dystrophy gave the following
recommendations:
All patients with Duchenne muscular dystrophy
should have a cardiac investigation (ECG and
echocardiogram) at diagnosis.
Next to this, patients with Duchenne muscular
dystrophy should have cardiac investigations
before any surgery, every 2 years to the age of
10 and annually after the age of 10 [11].
In female carriers an ECG and echocardiogram
should be performed at diagnosis or after the age of
16 years and at least every 5 years thereafter, or
more frequently in patients with abnormalities on
investigation or carriers with severe skeletal
muscle symptoms or cardiac symptoms.
The current study from Puchalski et al. and other
studies show that gadolinium enhanced MRI is able to
L. H. B. Baur (&)
Department of Cardiology, Atrium Medical Centre
Parkstad, University of Maastricht, Henri Dunantstreet 5,
6401CX Heerlen, The Netherlands
e-mail: l.baur@atriummc.nl
123
Int J Cardiovasc Imaging (2009) 25:69–70
DOI 10.1007/s10554-008-9371-8
detect cardiac fibrosis in patients with Duchenne
muscular dystrophy [12, 13]. The study showed, that
late gadolineum enhancement was negative related to
left ventricular ejection fraction. The cardiac involve-
ment was typically in inferolateral free wall and the
basal inferior and anterolateral region of the left
ventricle with sparing of the interventricular septum
and the right ventricle. Unfortunately, the authors did
not compare the MRI findings with electrocardio-
graphic or echocardiographic findings. This is of
clinical importance, because if MRI would be able to
detect cardiac involvement in patients with Duchenne
muscular dystrophy, early treatment with angiotensin
converting enzyme inhibitors or beta blockers could be
initiated. Therefore, there is a need for a comparative
study with electrocardiography, echocardiography and
MRI for early detection of cardiac involvement in
Duchenne muscular dystrophy. After this the main
effort has to be early treatment and prevention of left
ventricular dysfunction in this particular group of
patients.
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